Valuation: Traphaco

Market Cap 3,217B 122M 107M 99.86M 91.84M 172M 11.84B 175M 1.19B 466M 5.77B 459M 449M 20.03B P/E 2024
15.7x
P/E 2025 14.3x
Enterprise Value 2,647B 101M 88.46M 82.18M 75.58M 142M 9.74B 144M 983M 383M 4.75B 378M 369M 16.48B EV / Sales 2024
1.16x
EV / Sales 2025 0.96x
Free-Float
55.43%
Yield 2024
5.1%
Yield 2025 -
Jul. 20 Traphaco Joint Stock Company Announces to Pay Second Cash Dividend for the Year 2025, Payable on August 7, 2026 CI
Jul. 08 Traphaco Joint Stock Company Approves the Dismissal of Pham Hoang Anh from the Position Chief Finance & Planning Officer, Effective from July 06, 2026 CI
Jul. 08 Traphaco Joint Stock Company Approves the Dismissal of Pham Hoang Anh from the Position Chief Finance & Planning Officer, Effective from July 06, 2026 CI
Apr. 28 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Feb. 23 Traphaco Joint Stock Company Receives Large Enterprise Tax Department Decision on Tax Inspection and Administrative Penalties for Fiscal Years 2023 and 2024 CI
Jan. 29 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
Dec. 26 Traphaco Joint Stock Company Announces First Cash Dividend Payment in 2025, Payable on January 28, 2026 CI
Nov. 18 Traphaco Joint Stock Company Announces Change in Business Registration Certificate Issued by Hanoi Department of Finance CI
Nov. 09 Traphaco Joint Stock Company Announces Chief Executive Officer Changes, Effective November 10, 2025 CI
Nov. 05 Traphaco Joint Stock Company Announces Resignation of Ms. Nguyen Thi Giang as Member of the Board of Supervisors CI
25-10-29 Traphaco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-09-09 Traphaco Joint Stock Company Announces Dissolution of Branches CI
25-07-29 Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
1 day+2.11%
1 week-3.12%
Current month-2.02%
1 month-0.39%
3 months+0.52%
6 months+5.15%
Current year+3.47%
1 week 37,100
Extreme 37100
40,650
1 month 37,100
Extreme 37100
41,400
Current year 32,500
Extreme 32500
41,400
1 year 31,500
Extreme 31500
41,400
3 years 31,500
Extreme 31500
45,500
5 years 31,500
Extreme 31500
52,500
10 years 21,550
Extreme 21550
71,000
Manager TitleAgeSince
Chief Executive Officer 61 2012-09-16
Corporate Secretary - 2018-03-29
Comptroller/Controller/Auditor 44 1993-12-31
Director TitleAgeSince
Chairman 70 2010-10-17
Director/Board Member 61 1993-12-31
Director/Board Member 48 2016-03-29
Date Insider Type Main position Quantity % Market Cap.
4/15/25 Buy 33,264 0.0802%
10/5/23 Sell

Executive/Senior Manager

7,200 0.0174%
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%-3.12%+12.95%-14.73% 120M
+1.59%+1.07%+47.92%+157.28% 1,037B
+1.00%+3.33%+52.74%+50.98% 615B
+1.17%+0.97%+34.80%+79.39% 448B
+5.14%+5.40%+33.75%+27.79% 326B
+1.85%+3.57%+37.09%+40.59% 293B
-0.11%+0.48%+18.87%+17.70% 264B
+0.25%-4.62%-27.66%-41.76% 216B
+0.42%-1.23%+18.69%+55.90% 198B
-0.33%-4.76%+14.31%+67.15% 162B
Average +1.30%+0.91%+24.35%+44.03% 355.76B
Weighted average by Cap. +1.42%+1.47%+35.03%+75.48%

Financials

2024 2025
Net sales 2,347B 89.18M 78.44M 72.87M 67.02M 126M 8.64B 128M 871M 340M 4.21B 335M 328M 14.61B 2,657B 101M 88.8M 82.49M 75.87M 142M 9.78B 145M 986M 385M 4.77B 379M 371M 16.54B
Net income 239B 9.08M 7.99M 7.42M 6.82M 12.8M 879M 13.03M 88.73M 34.61M 429M 34.09M 33.36M 1.49B 250B 9.49M 8.34M 7.75M 7.13M 13.37M 919M 13.61M 92.68M 36.15M 448M 35.61M 34.84M 1.55B
Net Debt -540B -20.53M -18.06M -16.78M -15.43M -28.94M -1.99B -29.46M -201M -78.26M -970M -77.09M -75.42M -3.37B -569B -21.63M -19.03M -17.68M -16.26M -30.49M -2.1B -31.03M -211M -82.44M -1.02B -81.22M -79.46M -3.55B
Logo Traphaco
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Employees
1,546
Date Price Change Volume
26-07-22 38,800.00 +2.11% 2,745
26-07-22 ₫38,000.00 -0.52% 8,402
26-07-21 ₫38,200.00 +0.26% 11,227
26-07-20 ₫38,100.00 -2.81% 27,800
26-07-17 ₫39,200.00 -2.12% 11,600

Net sales - Rate of surprise